International Patent: USE OF ORMDL3 DEGRADATION AGENT IN HER2-POSITIVE DISEASE

GENEVA, June 26 -- ACADEMY OF MILITARY MEDICAL SCIENCES filed a patent application (CN2024/136133) for “USE OF ORMDL3 DEGRADATION AGENT IN HER2-POSITIVE DISEASE”. With publication no. WO/2026/117890, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/137

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....